DOCSLIB.ORG

As Infectious Diseases Physicians and Researchers, Microbiologist and Immunologists, Epidemiologists and Health Policy Leaders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
As Infectious Diseases Physicians and Researchers, Microbiologist and Immunologists, Epidemiologists and Health Policy Leaders September 9, 2020 Dear Colleagues, As infectious diseases physicians and researchers, microbiologist and immunologists, epidemiologists and health policy leaders, we stand united in efforts to develop and promote science-based solutions that advance human health and prevent suffering from the coronavirus pandemic. In this pursuit, we share a commitment to a basic principle derived from the Hippocratic Oath: Primum Non Nocere (First, Do No Harm). To prevent harm to the public’s health, we also have both a moral and an ethical responsibility to call attention to the falsehoods and misrepresentations of science recently fostered by Dr. Scott Atlas, a former Stanford Medical School colleague and current senior fellow at the Hoover Institute at Stanford University. Many of his opinions and statements run counter to established science and, by doing so, undermine public-health authorities and the credible science that guides effective public health policy. The preponderance of data, accrued from around the world, currently supports each of the following statements: The use of face masks, social distancing, handwashing and hygiene have been shown to substantially reduce the spread of Covid-19. Crowded indoor spaces are settings that significantly increase the risk of community spread of SARS-CoV-2. Transmission of SARS-CoV-2 frequently occurs from asymptomatic people, including children and young adults, to family members and others. Therefore, testing asymptomatic individuals, especially those with probable Covid-19 exposure is important to break the chain of ongoing transmission. Childrenof all ages can be infectedwith SARS-CoV-2.While infectionislesscommon in children than in adults, serious short-term and long-termconsequencesof Covid-19 are increasinglydescribed in children and young people. The pandemic will be controlledwhen a large proportionof a populationhas developed immunity(referredto as herd immunity)and that the safest path to herd immunityis through deploymentof rigorouslyevaluated,effective vaccines that have been approved by regulatoryagencies. Incontrast,encouragingherd immunitythrough uncheckedcommunitytransmissionis not a safe public healthstrategy. Infact, this approachwould do the opposite,causing a significantincreasein preventable cases, sufferingand deaths,especiallyamong vulnerablepopulations,such as older individualsand essential workers. Commitment to science-based decision-making is a fundamental obligation of public health policy. The rates of SARS-CoV-2 infection in the US, with consequent morbidity and mortality, are among the highest in the world. The policy response to this pandemic must reinforce the science, including that evidence-based prevention and the safe development, testing and delivery of efficacious therapies and preventive measures, including vaccines, represent the safest path forward. Failure to follow the science -- or deliberately misrepresenting the science – will lead to immense avoidable harm. We believe that social and economic activity can reopen safely, if we follow policies that are consistent with science. In fact, the countries that have reopened businesses and schools safely are those that have implemented the science-based strategies outlined above. As Stanford faculty with expertise in infectious diseases, epidemiology and health policy, our signatures support this statement with the hope that our voices affirm scientific, medical and public health approaches that promote the safety of our communities and nation. PhilipA.Pizzo,MD UpiSingh,MD BonnieMaldonado,MD Professorof Pediatrics Professorof Medicine Professorof Pediatrics (InfectiousDiseases)and of (InfectiousDiseaseand (InfectiousDiseases)and of Microbiologyand Immunology GeographicMedicine)andof EpidemiologyandPopulation andFormerDean,Stanford MicrobiologyandImmunology HealthChief,Divisionof Schoolof Medicineand andChief,Divisionof Infectious PediatricInfectiousDiseases FoundingDirector,Stanford Diseases andSenior AssociateDeanfor DistinguishedCareers Institute FacultyDevelopmentand Diversity LucyShapiro,PhD MelissaBondy,PhD MicheleBarry,MD ProfessorofDevelopmental Professorand Chair of ProfessorofMedicineand BiologyandDirector,BeckmanEpidemiologyandPopulation SeniorAssociateDeanfor CenterforMolecularand HealthandCo-Directorof the GlobalHealthandDirector, GeneticMedicine StanfordCenterfor Population CenterforInnovationinGlobal HealthSciences HealthandSeniorFellow, WoodsInstituteandthe FreemanSpogliInstitutefor InternationalStudies CharlesProber,MD JulieParsonnet,MD SteveGoodman,MD, MHS,PhD ProfessorofPediatricsandof ProfessorofMedicine MicrobiologyandImmunology(InfectiousDiseasesand ProfessorofEpidemiologyand andSeniorAssociateVice GeographicMedicine)andof PopulationHealthand ProvostforHealthEducation EpidemiologyandPopulation AssociateDeanofClinicaland Health TranslationalResearch DavidRelman,MD LeeM.Sanders,MD,MPH SteveLuby,MD ProfessorofMedicine AssociateProfessorofPediatrics ProfessorofMedicine (InfectiousDiseases)andof andofHealthResearchand (InfectiousDiseases) MicrobiologyandImmunologyPolicy(Epidemiology)and andofEpidemiology andSeniorFellow,Freeman Chief,DivisionofGeneral andPopulationHealth SpogliInstituteforInternationalPediatrics andSeniorFellow, Studies FreemanSpogliInstitute HarryGreenberg,MD AnnArvin,MD EdwardS Mocarski, Jr,PhD ProfessorofMedicineandof ProfessorofPediatrics MicrobiologyandImmunology(InfectiousDiseases)andof Professorof andAssociateDeanfor MicrobiologyandImmunology Microbiologyand Research andFormerViceProvostand Immunology,Emeritus DeanofResearch John Boothroyd,PhD John Carette, PhD DylanDodd,MD,PhD Professorof Microbiologyand Associate Professor of AssistantProfessorof Immunology Microbiology and Immunology Pathologyand of Microbiologyand Immunology JasonAndrews,MD,SM, DavidStuddert,LLB,MPH, MichelleMello,JD, DTM&H ScD PhD AssociateProfessorof Professorof Law andMedicine, Professorof Medicine(Health Medicine(InfectiousDiseases) StanfordHealthPolicy,Stanford Policy)andProfessorof Law andof Epidemiologyand Law School HealthPolicy Joshua Salomon,PhD ManuelRicardoAmieva,MD, LoreneNelson,PhD,MA PhD Professorof Medicine(Primary AssociateProfessorof CareandOutcomesResearch) Professorof Pediatrics EpidemiologyandPublic andSenior Fellow,Freeman (InfectiousDiseases)and of HealthandFacultyDirector SpogliInstitutefor International MicrobiologyandImmunology of the StanfordCenterfor Studies PopulationHealthSciences AbrahamVergheseMD, ArunaSubramanian,MD DeanL.Winslow,MD,FACP, MACP,FRCP(Edin) FIDSA,FPIDS ClinicalProfessorof Medicine, LindaR.Meierand Joan F. Chief,Immunocompromised Professorof Medicine– Lane ProvostialProfessor, Host InfectiousDiseases InfectiousDiseases ViceChairfor the Theoryand Divisionof InfectiousDiseases Practiceof Medicine andGeographicMedicine StephenJ Galli,MD Helen M Blau, PhD JasonWang,MD,PhD Professorof Pathologyandof Professor of Microbiology and AssociateProfessorof Pediatrics Microbiologyand Immunology Immunology and Director, andMedicineandof Health andFormerChair,Department Baxter Laboratory for Stem Cell ResearchandPolicyand of Pathology Biology Director,Centerfor Policy, Outcomesand Prevention AnnHsing,PhD,MPH SteveAsch,MD,MPH EstherJohn,PhD,MSPH Professorof Medicine(Stanford Professorof Medicine,Primary Professor,Departmentof PreventionResearch CareandPopulationHealth EpidemiologyandPopulation Center/CancerInstitute)and HealthandCo-leader, Epidemiologyand Population PopulationSciencesProgram, Health StanfordCancerInstitute ThomasC Merigan,MD DavidA. Stevens,M.D., GaryK.Schoolnik,MD F.A.C.P.,F.A.A.M.,F.I.D.S.A. Professorof Medicine,Emeritus Professorof Medicine- FormerDivisionChief Director, Professorof Medicine- InfectiousDiseases,Emeritus Centerfor Aids Research, InfectiousDiseases,Emeritus Emeritus andPresident,California Institutefor MedicalResearch, InfectiousDiseasesResearch Laboratory,Calif.Inst.for Med. Res. Jack Remington,MD Cornelia L.Dekker, MD Denise Monack, PhD Professorof Medicine Professor of Pediatrics Professor of Microbiology and (InfectiousDiseases)and Chief, (Infectious Diseases), Emerita Immunology PaloAltoMedicalResearch Foundation Stan Deresinski,MD,FIDSA ShiritEinav,MD RobertShafer,MD ClinicalProfessorof Medicine AssociateProfessorMedicine- Professorof MedicineDivision InfectiousDiseasesand InfectiousDiseasesand of InfectiousDiseasesand GeographicMedicine GeographicMedicineand of GeographicMedicine Microbiologyand Immunology Holden Terry Maecker, PhD Wah Chiu, PhD Doug K Owens, MD, MS Professor of Microbiology and Professor of Bioengineering and Professor of Medicine and Immunology of Microbiology and Senior Fellow, Freeman Spogli Immunology Institute for International Studies Cybele A.Renault,MD, JakeScott,MD Justin Sonnenburg,PhD DTM&H ClinicalAssistantProfessorof AssociateProfessorof ClinicalAssociate Professor MedicineInfectiousDiseases MicrobiologyandImmunology (InfectiousDiseases)Program andGeographicMedicine andCo-Director,Centerfor Lead for Global Health HumanMicrobiomeStudies (StanfordInternalMedicine ResidencyProgram) Hector Bonilla, MD Dora Ho, MD, PhD MarisaHolubar,MDMS Clinical Associate Professor of Clinical Associate Professor of ClinicalAssociateProfessorof Medicine Infectious Diseases Medicine Infectious Diseases MedicineInfectiousDiseases and Geographic Medicine and Geographic Medicine andGeographicMedicineand AssociateDirector,Stanford AntimicrobialSafetyand SustainabilityProgram Sharon Chen,MD,MS RoshniMatthew,MD Elizabeth S. Egan, MD,PhD ClinicalAssociate Professor of ClinicalAssistantProfessorof Assistant
Load more

Recommended publications
  • COVID-19. Rarely Does the World Offer Proof of an Academic Argument, and Even More Rarely in a Single Word Or Term
    PREFACE TO THE PAPERBACK uU COVID-19. Rarely does the world offer proof of an academic argument, and even more rarely in a single word or term. But there it is. COVID-19 has shown us in the starkest terms—life and death—what happens when we don’t trust science and defy the advice of experts. As of this writing, the United States leads the world in both total cases and total deaths from COVID-19, the disease caused by the novel coronavirus that appeared in 2019. One might think that death rates would be highest in China, where the virus first emerged and doctorswere presumably caught unpre- pared, but that is not the case. According to The Lancet— the world’s premier medical journal—as of early October 2020, China had confirmed 90,604 cases of COVID-19 and 4,739 deaths, while the United States had registered 7,382,194 cases and 209,382 deaths.1 And China has a population more than four times that of the United States. If the United States had a pandemic pattern similar to China, we would have seen only 22,500 cases and 1128 deaths. While COVID-19 has killed people across the globe, death rates have been far higher in the United States than in other wealthy countries, such as Germany, Iceland, South Korea, New Zealand, and Taiwan, and even than in some much poorer x • Preface to the Paperback countries, such as Vietnam.2 The Johns Hopkins University School of Medicine puts the US death rate per 100,000 people at 65.5.3 In Germany it is 11.6.
    [Show full text]
  • Eka-Weekly-Covid-Update-12
    Weekly COVID-19 Update From EKA December 2, 2020 Coronavirus Deaths Soar The US has reported more than 13.5 million cases and 268,000 deaths. Globally, there have been 63 million cases and 1.47 million fatalities. In November alone, one of every 76 Americans tested positive for COVID-19, and the country reported 36,918 deaths – a toll greater than American losses in the Korean War. The Safer at Home order has been in place in Los Angeles since March 19. Previous EKA COVID-19 updates Our previous COVID-19 updates can be found here. Feel free to share our updates with friends and colleagues. We hope you find the information in the EKA updates and the questions they raise to be informative. If you have any COVID-19 government or communications questions, please reach out to any EKA team members. Confirmed Or Suspected Cases Of COVID-19 At Work – What Do You Need To Do The Health Department has created a document that updates the close contact definition and requirements around who must quarantine and isolate. Also provided is additional updated information on the management of symptomatic staff or visitors. Click here to view FAQs for Managers Coronavirus Disease (COVID-19) from the Los Angeles County Department of Public. Click here to view Protocols for Office Worksites. Click here to view some of the protections that employers are required to put in place. Click here to view the office worksite toolkit. OPENING/ CLOSING & RESTRICTIONS New LA County Order The Los Angeles County Health Officer Safer at Home Health Officer Order took effect on Monday and ends on December 20, 2020.
    [Show full text]
  • When Physicians Engage in Practices That Threaten the Nation's Health
    Opinion When Physicians Engage in Practices VIEWPOINT That Threaten the Nation’s Health Philip A. Pizzo, MD In December 2020, less than a year after severe acute young people are not harmed by the virus and cannot Departments of respiratory syndrome coronavirus 2 was identified as spread the disease; reportedly pressured the Centers for Pediatrics and the cause of the coronavirus pandemic, an extraordi- Disease Control and Prevention to issue guidance (later Microbiology and nary collaboration between scientists, the pharmaceuti- reversed)statingthatasymptomaticindividualsneednot Immunology, Stanford 4 University School of cal industry, and government led to 2 highly efficacious, be tested ; and made unsupported claims about the im- Medicine, Stanford, safe vaccines being approved by the US Food and Drug munity conferred by surviving infection. Nearly all pub- California. Administration to prevent coronavirus disease 2019 lic health experts were concerned that his recommen- (COVID-19) infection.1,2 Had the US been in its expected dations could lead to tens of thousands (or more) of David Spiegel, MD role as a global leader in medicine and public health, this unnecessary deaths in the US alone. Department of Psychiatry and would have been a fitting capstone of US commitment to History is a potent reminder of tragic circum- Behavioral Sciences, science and how that can change the course of morbid- stances when physicians damaged the public health, Stanford University ity and mortality related to a frightening new disease. from promoting eugenics to participating in the human School of Medicine, Stanford, California. However, a less flattering story emerged about the experiments that took place in Tuskegee to asserting er- inadequate US response to COVID-19.
    [Show full text]
  • Political Polarization and the Dissemination of Misinformation: the United States Pandemic Response As a Cautionary Tale
    The University of Maine DigitalCommons@UMaine Honors College Spring 5-2021 Political Polarization and the Dissemination of Misinformation: the United States Pandemic Response as a Cautionary Tale Mary Giglio Follow this and additional works at: https://digitalcommons.library.umaine.edu/honors Part of the American Politics Commons This Honors Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in Honors College by an authorized administrator of DigitalCommons@UMaine. For more information, please contact [email protected]. POLITICAL POLARIZATION AND THE DISSEMINATION OF MISINFORMATION: THE UNITED STATES PANDEMIC RESPONSE AS A CAUTIONARY TALE by Mary K. Giglio A Thesis Submitted in Partial Fulfillment of the Requirements for a Dual-Degree with Honors (International Affairs and Political Science) The Honors College The University of Maine May 2021 Advisory Committee: Richard Powell, Professor of Political Science, Advisor Mark Brewer, Professor of Political Science, Honors College Lora Pitman, Adjunct Assistant Professor of Political Science Asif Nawaz, Assistant Professor of History and International Affairs Zachary Rockwell Ludington, Assistant Professor of Spanish i ABSTRACT This thesis discusses the failings of the United States response to the COVID-19 pandemic, and how it has been shaped by the nation’s intense political polarization and the widespread dissemination of misinformation. In this thesis, I critically examine the government’s initial response to the pandemic, including its lack of preparedness and the ineffectiveness of its eventual policies. I also attempt to explain the influence of political polarization on the states, resulting in congressional gridlock, as well as wildly varying policies regarding lockdowns and mask mandates.
    [Show full text]
  • Kentucky Hospital Research & Education Foundation Emergency
    Kentucky Hospital Research & Education Foundation Emergency Preparedness Update for September 3, 2020 National Preparedness Month (ASPR) National Preparedness Month (NPM) is recognized each September to promote family and community disaster planning now and throughout the year. As our nation continues to respond to COVID-19, there is no better time to be involved this September. The 2020 NPM theme is "Disasters Don't Wait. Make Your Plan Today." Ready.gov has built a NPM toolkit for stakeholders to distribute through their communication channels. The toolkit includes weekly themes, social media and graphics, videos, and other resources. This week, we remind individuals to create a family disaster kit. A disaster supplies kit is a collection of basic items your household may need in an emergency. Make sure your kit is stocked with the items from this FEMA checklist. This year, addition emergency supplies are needed in your kit to help prevent the spread of coronavirus. Be sure you kit includes these CDC-recommended supplies: Two cloth face coverings for everyone age 2 and older Hand sanitizer with at least 60% alcohol, and bar or liquid soap Disinfecting wipes to disinfect surfaces ---------- KY COVID-19 - Daily Summary New cases today: 906; Total 509,885 New deaths today: 10; Total 976 Total PCR Tests: 839,705; Positivity Rate: 4.53% See Governor’s Press Releases: https://governor.ky.gov/news ---------- Four Midwestern states are seeing worrying COVID-19 spikes Most of the Midwest had been spared the worst of Covid-19 — until now. The coronavirus is always restless, always searching for new people in new places to infect.
    [Show full text]
  • Dr. Rick Bright, One of the Nation's Leading Experts in Pandemic
    THIRD ADDENDUM TO THE COMPLAINT OF PROHIBITED PERSONNEL PRACTICE AND OTHER PROHIBITED ACTIVITY BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBMITTED BY DR. RICK BRIGHT I. Introduction Dr. Rick Bright, one of the nation’s leading experts in pandemic preparedness and response, and an internationally recognized expert in the fields of immunology, therapeutic intervention, and vaccine and diagnostic development, was abruptly removed from his position as Director of the Biomedical Advanced Research and Development Authority (“BARDA”) and transferred to a limited position at the National Institutes of Health (“NIH”) in retaliation for his whistleblowing activity under 5 U.S.C. § 2302(b)(8)(A). Specifically, and as detailed in his initial Complaint of Prohibited Personnel Practice filed with the Office of Special Counsel (“OSC”) on May 5, 2020, Secretary of Health and Human Services, Alex Azar, and other HHS political leaders engaged in an overtly hostile and career-derailing campaign of retaliation against Dr. Bright because he raised concerns about the Trump administration’s chaotic and reckless response to the COVID-19 pandemic. Shortly after cases of COVID-19 were identified in the United States, Dr. Bright sounded the alarm about the shortage of critical supplies, such as masks, respirators, swabs, and syringes that were necessary to combat COVID-19. In response, HHS political leadership leveled baseless criticisms against him and sidelined him because of his insistence that the Trump administration address these shortages and invest in vaccine development as well. Dr. Bright continued to speak out about the inevitable devastation that would be wrought by this virus at a time President Trump and his administration were intentionally lying to the American people about the serious threat posed by COVID-19 to the public health and safety.1 Dr.
    [Show full text]
  • A Seat at the Table: the Key Role of Biostatistics and Data Science During the Pandemic
    A Seat at the Table: The Key Role of Biostatistics and Data Science during the Pandemic Jeffrey S. Morris Director, Division of Biostatistics Professor, Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine Professor, Department of Statistics The Wharton School University of Pennsylvania May 27, 2021 Centrality of Statistics in the Pandemic Biomedical Data Science: emerging field including computer science, computational biology, informatics, statistics that together is involved in extracting knowledge from ever more complex and abundant data in biomedical research Statistics plays a central role in data science given expertise • Experimental design and reproducibility of research • Deep understanding of variability, measurement error, missing data, correlated data, and causal inference. • Fundamental understanding of inferential thinking • Quantification of uncertainty • Modeling frameworks for integrative learning across studies 2 Centrality of Statistics in the Pandemic Statistical thinking crucial to evaluate emerging knowledge • Properly interpret various types of data: testing/case/hospitalization/death • Evaluate strength of evidence of emerging insights from papers/preprints • Cut through political and other narratives to identify what the data say • Synthesize information across different types of studies to identify knowledge • Clearly communicate results and their limitations and uncertainties Engagement/Impact on Broader Society: Efforts during Pandemic • Covid-datascience.com blog page • COVID-Lab
    [Show full text]
  • Exoskeletal Assemblages: on the Disembodiments of Being Misread by Patricia J
    Exoskeletal Assemblages: On the Disembodiments of Being Misread By Patricia J. Williams Copyright, 2021 This essay is a draft prepared for the exclusive use of the Law and Gender Colloquium at Northwestern University, April 7, 2021, and is not for wider circulation. It is the first chapter of a book I'm working on, about the disassembling and disembodying effects of new technology. This piece of the project (parts of which will be published in a public health handbook) is mostly about how race and gender history is woven into present assemblages, particularly with regard to the pandemic. Chapter One Micro to Macro We were in first grade together, the woman who used to call me her Best Black Friend. I cured her of that years later, but still, after a lifetime of valiant trying on both our parts, she retains the power to startle. There we were, having a perfectly amiable chat about actor James Earl Jones’s lusciously resonant baritone when she said: “it must be because of the way black people’s larynxes are shaped. You can hear the difference in the how their vocal cords affect sound.” I was so taken aback by her sudden slippage into an imaginary plural that I could not speak. She saw that I was struggling. “It’s probably why you have such a beautiful voice,” she added gently, as though application of the aggregate singular might help.1 I have been thinking a lot about my friend over the course of this last tumultuous pandemic-riled year. We are obviously all derailed by the catastrophe of COVID-19, no matter what our relative privilege or status.
    [Show full text]
  • COVID-19 Update from EKA – August 19, 2020 LOS ANGELES
    COVID-19 Update From EKA – August 19, 2020 Five Months Ago, The World Changed Today is day 153 of the statewide "Stay-at-Home" Order. 161 days ago, the World Health Organization declared COVID-19 a Pandemic. Safer at Home orders have been in place in Los Angeles since March 19. Previous EKA COVID-19 updates Our previous COVID-19 updates can be found here. Feel free to share our updates with friends and colleagues. We hope you find the information in the EKA updates and the questions they raise to be informative. If you have any COVID-19 government or communications questions, please reach out to any member of the EKA team. If you have a specific COVID-19 question, click here and we will attempt to answer it in our update LOS ANGELES COUNTY Colleges and Universities Must Continue Distance Learning Colleges and universities in Los Angeles County may continue their essential operations, but most academic instruction must continue to be done via distance-learning. Institutions may continue to offer in-person training and instruction only for students who are or will become part of the essential workforce and only for required activities that cannot be accomplished through virtual learning. All other academic instruction must continue to be done via distance- learning. Faculty and other staff may come to campus to provide distance learning, and other activities related to the purposes above, as well as maintaining minimum basic operations. Colleges and universities should limit their on-campus student residency to only providing housing for students who have no alternative housing options.
    [Show full text]
  • Assessing the Response to COVID-19 in the United States
    ASSESSING THE U.S. RESPONSE TO COVID-19 1 Pandemic Politics: Assessing the Response to COVID-19 in the United States Shalini Nair Department of Epidemiology College of Public Health and Health Professions University of Florida Spring 2021 ASSESSING THE U.S. RESPONSE TO COVID-19 2 Table of Contents Abstract ...........................................................................................................................................3 Pandemic Politics: Assessing the Response to COVID-19 in the United States .......................4 Public Health Governance ............................................................................................................4 Grounds for Assessment ...............................................................................................................5 Data Collection ...............................................................................................................................6 Findings ...........................................................................................................................................6 Investment in Infrastructure .........................................................................................................7 Immediate Action .........................................................................................................................9 Political Motives ........................................................................................................................11 Socioeconomic Impact and Disparities
    [Show full text]
  • Vaccines and Global Health :: Ethics and Policy
    Vaccines and Global Health: The Week in Review 24 October 2020 :: Number 576 Center for Vaccine Ethics & Policy (CVEP) This weekly digest targets news, events, announcements, articles and research in the vaccine and global health ethics and policy space and is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. Vaccines and Global Health: The Week in Review is published as a PDF and scheduled for release each Saturday evening at midnight [0000 GMT-5]. The PDF is posted and the elements of each edition are presented as a set of blog posts at https://centerforvaccineethicsandpolicy.net. This blog allows full-text searching of over 9,000 entries. Comments and suggestions should be directed to David R. Curry, MS Editor and Executive Director Center for Vaccine Ethics & Policy [email protected] Request email delivery of the pdf: If you would like to receive the PDF of each edition via email [Constant Contact], please send your request to [email protected]. Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution. Contents [click on link below to move to associated content] A. Milestones :: Perspectives :: Featured Journal Content B. Emergencies C.
    [Show full text]
  • Covid-19: Group of UK and US Experts Argues
    NEWS BMJ: first published as 10.1136/bmj.m3908 on 7 October 2020. Downloaded from New York Cite this as: BMJ 2020;371:m3908 Covid-19: Group of UK and US experts argues for “focused protection” http://dx.doi.org/10.1136/bmj.m3908 instead of lockdowns Published: 07 October 2020 Jeanne Lenzer Thousands of medical practitioners and public health Benefits and harms scientists have signed a declaration arguing for an On Monday the declaration’s authors met with Alex alternative public health approach to dealing with Azar, US secretary of health and human services, and covid-19. Scott Atlas, an adviser to President Trump, for what The Great Barrington Declaration,1 published on Kulldorff described as a “very good discussion.”6 Monday 5 October, was drawn up by three However, Stefan Baral, a physician epidemiologist epidemiologists and public health experts from and associate professor at Johns Hopkins University, Harvard, Oxford, and Stanford universities, who said he was concerned that the meeting had taken describe their approach as “focused protection” of place. Baral explained that, while he generally agreed the people most at risk. that lockdowns were causing serious harms, he had As of Wednesday 7 October almost 6300 medical declined to sign the declaration because it did not practitioners and public health scientists from the address the concrete steps needed to assist the most US, the UK, and other nations had signed the vulnerable people. declaration. Baral told The BMJ that three steps must accompany The authors—Martin Kulldorff, professor of medicine any loosening of restrictions: firstly, the removal of at Harvard, Sunetra Gupta, professor of theoretical any barriers to accessing healthcare; secondly, paid epidemiology at Oxford, and Jay Bhattacharya, leave for people affected by covid-19; and lastly, professor of medicine and economics at housing support for such people in multigenerational Stanford—said that because older people were 1000 households.
    [Show full text]